Ginkgo Bioworks Holdings, Inc.
DNA· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $43.64M | — |
| Net Income | -$53.94M | -$28.73M |
| EPS Diluted | -$0.04 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ginkgo Bioworks Holdings, Inc. · CIK 1830214 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end